| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are sulfonylureas passé?
|
Green, Jennifer B.
|
|
2006
|
6 |
5 |
p. 373-377
|
artikel
|
| 2 |
Are thiazolidinediones good or bad for the heart?
|
Taylor, Angela M.
|
|
2006
|
6 |
5 |
p. 378-383
|
artikel
|
| 3 |
Cardiovascular risk assessment in type 2 diabetes mellitus
|
Al-Ozairi, Ebaa
|
|
2006
|
6 |
5 |
p. 333-336
|
artikel
|
| 4 |
Community-based programming to treat childhood obesity
|
Morris, Vivien
|
|
2006
|
6 |
5 |
p. 395-400
|
artikel
|
| 5 |
Does a low-fat dietary intervention reduce CVD risk?
|
Jackson, Sharon D.
|
|
2006
|
6 |
5 |
p. 387-388
|
artikel
|
| 6 |
How do different GLP-1 mimetics differ in their actions?
|
Choukem, Simeon Pierre
|
|
2006
|
6 |
5 |
p. 365-372
|
artikel
|
| 7 |
Interpreting the Joslin diabetes center and joslin clinic clinical nutrition guideline for overweight and obese adults with type 2 diabetes
|
Giusti, Judy
|
|
2006
|
6 |
5 |
p. 405-408
|
artikel
|
| 8 |
Is glycemic variability important to assessing antidiabetes therapies?
|
Kovatchev, Boris P.
|
|
2006
|
6 |
5 |
p. 350-356
|
artikel
|
| 9 |
Is the metabolic syndrome a real clinical entity and should it receive drug treatment?
|
Darsow, Tamara
|
|
2006
|
6 |
5 |
p. 357-364
|
artikel
|
| 10 |
Orlistat: Current issues for patients with type 2 diabetes
|
Mancino, Juliet M.
|
|
2006
|
6 |
5 |
p. 389-394
|
artikel
|
| 11 |
Pramlintide: A new tool in diabetes management
|
Want, Laura L.
|
|
2006
|
6 |
5 |
p. 344-349
|
artikel
|
| 12 |
Web alert
|
|
|
2006
|
6 |
5 |
p. 337-338
|
artikel
|
| 13 |
What can the national weight control registry teach us?
|
Daeninck, Elizabeth
|
|
2006
|
6 |
5 |
p. 401-404
|
artikel
|
| 14 |
What to inject when oral agents fail?
|
McCall, Anthony L.
|
|
2006
|
6 |
5 |
p. 341-343
|
artikel
|
Tijdschrift beschrijving